A prospective, double‐blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

Bin Nie, Yujie Zhou, Yanfang Li et al.|Catheterization and Cardiovascular Interventions|2008

Cited by 62